Analysis of manufacturing costs in pharmaceutical companies

Journal of Pharmaceutical Innovation

Volumn 3, Issue 1, 2008, Pages 30-40

  Basu, Prabir ^a   Joglekar, Girish ^a   Rai, Saket ^a   Suresh, Pradeep ^a   Vernon, John ^b  

^a PURDUE UNIVERSITY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

COGS; Pharmaceutical manufacturing

Indexed keywords

DRUG; GENERIC DRUG;

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BIOTECHNOLOGY; CONTROLLED STUDY; COST; COST CONTROL; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG NOMENCLATURE; ECONOMIC EVALUATION; INCOME; INVESTMENT; PRIORITY JOURNAL; SOCIETY; THEORETICAL STUDY; TREND STUDY;

EID: 42449120920     PISSN: 18725120     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12247-008-9024-4     Document Type: Article

References (8)

1. Reinhardt UE. Perspectives on the pharmaceutical industry. Health Aff. 2001;20(5):1363-70.
2. Kaiser Family Foundation Report, September 2007.
3. Suresh P, Basu PK. Improving pharmaceutical product development and manufacturing: Impact on cost of drug development and cost of goods sold of pharmaceuticals. Pharmaceutical Technology & Education Center, Purdue University, February 2006.
4. PhRMA Report. What goes into the cost of a prescription drug? 2006.
5. Abboud L, Hensley S. Factory shift: New prescription for drug makers. The Wall Street Journal 2003;September 3.
6. IMS. Global pharmaceutical market forecast. 2008.
7. Vernon JA, Keener HW, Trujillo AJ. Pharmaceutical manufacturing efficiency, drug prices, and public health: Examining the casual links. Drug Inf J. 2007;41:229-39.
8. Wharton Research Data Services (WRDS). Compustat. http://wrds.wharton.upenn.edu/.